Tuesday, August 12, 2025

Fund Houses Update - 12 August 2025

Dear Trader... 

Fund Houses Recommendations

  • Jefferies on HCL tech: Maintain Buy on Company, target price at Rs 1850/Sh (Positive)
  • HSBC on Info Edge: Upgrade to Buy on Company, raise target price at Rs 1670/Sh (Positive)
  • Nuvama on Bajaj Consumer: Maintain Buy on Company, target price at Rs 274/Sh (Positive)
  • Jefferies on Belrise: Maintain Buy on Company, target price at Rs 135/Sh (Positive)
  • Macquarie on Lemon Tree: Maintain Outperform on Company, target price at Rs 200/Sh (Positive)
  • Nuvama on AMCs: Sees record 56,540 cr equity inflows in July, bullish on HDFCAMC & NAM for earnings rebound (Positive)
  • Citi on Pharma: USFDA has approved two generic versions of Iron Sucrose & both may be eligible for 180-days of CGT exclusivity. Among Indian generics, Iron Sucrose was an important pipeline product for Dr Reddy’s & Aurobindo Pharma (Neutral)
  • Antique on BEML: Maintain Buy on Company, cut target price at Rs 4921/Sh (Neutral)
  • MOSL on Nippon AMC: Maintain Buy on Company, target price at Rs 930/Sh (Neutral)
  • Jefferies on Entero: Maintain Hold on Company, target price at Rs 1350/Sh (Neutral)
  • Citi on Concord: Maintain Neutral on Company, target price at Rs 1880/Sh (Neutral)
  • MS on Titagarh Rail: Maintain Overweight on Company, target price at Rs 1027/Sh (Neutral)
  • MS on Astral: Maintain Equal weight on Company, target price at Rs 1489/Sh (Neutral)
  • CLSA on Astral: Maintain Hold on Company, target price at Rs 1515/Sh (Neutral)
  • Jefferies on Hindalco: Maintain Hold on Company, target price at Rs 690/Sh (Neutral)
  • CLSA on Hindalco: Maintain Outperform on Company, target price at Rs 850/Sh (Neutral)
  • Nuvama on Hindalco: Maintain Buy on Company, target price at Rs 776/Sh (Neutral)
Warm Regards...

Nikhil Bhatt
Business Editor
Investment Point
Contact :- 99390 80808
www.nikhilbhatt.in

The securities quoted are for illustration only and are not recommendatory. Investment in securities market are subject to market risks. Read and agree Disclaimer and related all the documents carefully before investing, mentioned on www.nikhilbhatt.in

No comments:

Post a Comment